✦ LIBER ✦

Use of a comprehensive panel of biomarkers to predict response to a fluorouracil–oxaliplatin regimen in patients with metastatic colorectal cancer

✍ Scribed by Lamas, Maria J; Duran, Goretti; Balboa, Emilia; Bernardez, Beatriz; Touris, Manuel; Vidal, Yolanda; Gallardo, Elena; Lopez, Rafael; Carracedo, Angel; Barros, Francisco

Book ID: 118197309
Publisher: Future Medicine
Year: 2011
Tongue: English
Weight: 701 KB
Volume: 12
Category: Article
ISSN: 1462-2416
DOI: 10.2217/pgs.10.196

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gene expression signature and response t

Gene expression signature and response to the use of leucovorin, fluorouracil and oxaliplatin in colorectal cancer patients

✍ Toshiaki Watanabe; Takashi Kobunai; Yoko Yamamoto; Keiji Matsuda; Soichiro Ishih 📂 Article 📅 2011 🏛 Springer Milan 🌐 Spanish ⚖ 473 KB

A randomised phase II study of oxaliplat

A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patients

✍ A. Zori Comba; C. Blajman; E. Richardet; S. Bella; M. Vilanova; F. Cóppola; M. V 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Addition of Aflibercept to Fluorouracil,

Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

✍ Van Cutsem, E.; Tabernero, J.; Lakomy, R.; Prenen, H.; Prausova, J.; Macarulla, 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 532 KB

A Phase II Study of Oxaliplatin, 5-Fluor

A Phase II Study of Oxaliplatin, 5-Fluorouracil, Leucovorin, and High-Dose Capecitabine in Patients With Metastatic Colorectal Cancer

✍ Sam J. Lubner; Noelle K. LoConte; Kyle D. Holen; William Schelman; James P. Thom 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 117 KB

Comparison of toxicity profiles of fluor

Comparison of toxicity profiles of fluorouracil versus oxaliplatin regimens in a large population-based cohort of elderly patients with colorectal cancer

✍ Cen, P.; Liu, C.; Du, X. L. 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 118 KB

Pharmacokinetic/pharmacodynamic modeling

Pharmacokinetic/pharmacodynamic modeling of 5-fluorouracil by using a biomarker to predict tumor growth in a rat model of colorectal cancer

✍ Kobuchi, Shinji; Ito, Yukako; Okada, Kae; Imoto, Kazuki; Kuwano, Shota; Takada, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 627 KB